Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Pivotal Study Assessing the Safety and Efficacy of Targeted Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound During the Standard of Care Treatment of Brain Metastases of Non-small Cell Lung Cancer (NSCLC) Origin

NCT05317858 is registered in ClinicalTrials.gov with InSightec as lead sponsor.

NCT NCT05317858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05317858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Pivotal Study Assessing the Safety and Efficacy of Targeted Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound During the Standard of Care Treatment of Brain Metastases of Non-small Cell Lung Cancer (NSCLC) Origin
Lead sponsor
InSightec
Phase
Phase 3
Overall status
Recruiting
Start date
August 12, 2022
Completion date
December 1, 2031
Enrollment
96 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, non small cell lung cancer